Floatz logo

ATENOLOL

Vestibular Disorder

Massachusetts Eye and Ear InfirmarySmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Vestibular Disorder cohort.

Asset / SponsorPhaseRating
Fampridine
Massachusetts Eye and Ear Infirmary
Phase 2CCC

Same molecule, other indications

ATENOLOL is also rated in:

stroke disorderDormant
BBB
Indicative ·
75 / 100
View asset →
myocardial ischemiaDormant
BBB
Indicative ·
75 / 100
View asset →
hypertensive disorderDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →